|
|
|
|
|
|
|
|
If
you dont have an Acrobat Reader installed on your computer, you
may download it for free from the link below:
|
|
|
|
|
Impact of an Anemia Clinic on
Emergency Room Visits and
Hospitalizations in Patients with
Anemia of CKD Pre-Dialysis
(Vol
34/No. 2. On-line test expires: 04/20/2009)
|
To
receive continuing education credit, you must read the
information in this article and take an on-line post
test and fill out an on-line program evaluation form.
The certificate will then be generated for you as a
.pdf file which you can print out locally on your computer.
CE Certification by ANNA requires a handling charge
that must be paid by credit card. Pricing information
is available by clicking on the "Post-Test Evaluation"
link below.
|
|
|
|
Please
download and print the PDF file below:
|
|
|
|
Robert M. Perkins, MD
|
Robert M. Perkins, MD, is Director of Dialysis,
Department of Medicine/Nephrology Service,
Walter Reed Army Medical Center, Washington,
DC.
|
|
Stephen Olson, MD
|
Stephen Olson, MD, is Staff Physician,
Department of Medicine/Nephrology Service,
Walter Reed Army Medical Service, Washington,
DC.
|
|
Janice Hansen, RN
|
Janice Hansen, RN, is Head Nurse, Department
of Medicine/Nephrology Service, Madigan Army
Medical Center, Tacoma, WA.
|
|
Joseph Lee, DO
|
Joseph Lee, DO, is Staff Nephrologist, Kidney
Specialists of Minnesota, Roseville, MN.
|
|
Kevin Stiles, MD
|
Kevin Stiles, MD, is Chief of Nephrology, Kaiser
Permanente, Bakersfield, CA.
|
|
Christopher Lebrun, MD
|
Christopher Lebrun, MD, is Vice President,
Nephrology Associates PC, Columbus, MS.
|
Aim. There is limited data regarding the impact on hospital resource use of a dedicated,
nurse-managed anemia clinic in patients with pre-end stage chronic kidney disease.
Methods. A retrospective cohort study was conducted comparing patients with pre-end stage
anemia of chronic kidney disease enrolled in an algorithmic anemia clinic (N = 27, treatment
group) with un-enrolled patients with chronic kidney disease (N = 22, control group).
The treatment group received algorithmic treatment with recombinant human erythropoietin
and intravenous iron sucrose, while controls received usual care. The primary outcomes
investigated were emergency room visits and hospitalizations during a 1-year period.
Results. The two groups were similar at baseline. During the first year of clinic enrollment,
the mean hemoglobin values improved in the treatment group from baseline and compared
with controls (11.6 ± 1.2 g/dl vs. 10.3 ± 1.0 g/dl, p < 0.05). The relative risk of an emergency
room visit (RR 0.18, 95% CI 0.05-0.67, p < 0.05) and hospitalization (RR 0.20, 95% CI
0.06-0.67, p < 0.05) were reduced in the treatment group versus the control group. The average
length of hospital stay was also reduced (6.8 days vs. 9.5 days, p = 0.05).
Conclusion. Enrollment in a dedicated nurse-managed anemia clinic is significantly associated
with reduced emergency room visits and hospitalizations in patients with pre-end stage
CKD. These associative findings justify future prospective analyses to establish causality.
|
CE
RELATED INFORMATION |
|
This
offering for 1.4 contact
hours is being provided by
the
American
Nephrology Nurses Association
(ANNA), which
is accredited as a provider
and approver of continuing
education in nursing by
the American Nurses
Credentialing Center-Commission
on Accreditation (ANCCCOA).
This educational activity
is approved by most states
and specialty organizations
that recognize the ANCC-COA
accreditation process. ANNA
is an approved provider of
continuing education in nursing
by the California Board of
Registered Nursing, BRN Provider
No. 00910; and the Kansas
State Board of Nursing, Provider
No. LT0148-0738. This offering
is accepted for RN and LPN
relicensure in Kansas
|
|
Goal:
To describe the effects of a nurse-managed, algorithmic treatment plan for anemia
on emergency room visits and hospitalizations in patients with chronic kidney
disease.
Objectives:
1. Summarize the effects of a nurse-managed, algorithmic treatment of
patients with anemia and CKD.
2. Relate the limitations of a study done on patients with anemia and CKD.
3. Generate ideas for future studies on the management of anemia in patients
with CKD.
|
AUTHOR DISCLOSURE
STATEMENT |
Robert M. Perkins
has no conflicts of interest to disclose.
Stephen Olson
has no conflicts of interest to disclose.
Janice Hansen
has no conflicts of interest to disclose.
Joseph Lee
has no conflicts of interest to disclose.
Kevin Stiles
has no conflicts of interest to disclose.
Christopher Lebrun
has no conflicts of interest to disclose.
|
ANNA and HDCN CE POLICY STATEMENTS |
The CE policy and disclosure statements of the American Nephrology
Nurses' Association are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are listed on
this page. |
|
|
|
| |